Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Long-Term Oncological Outcome After Conventional Radical Hysterectomy Versus 2 Nerve-Sparing Modalities for Early Stage Cervical Cancer.

van Gent MDJM, Rademaker M, van der Veer JCB, van Poelgeest MIE, Gaarenstroom KN, Putter H, Trimbos JBMZ, de Kroon CD.

Int J Gynecol Cancer. 2017 Oct;27(8):1729-1736. doi: 10.1097/IGC.0000000000001067.

PMID:
28704329
2.

Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents.

van Haaften C, van Eendenburg J, Boot A, Corver WE, Haans L, van Wezel T, Trimbos JB.

Int J Gynecol Cancer. 2017 Oct;27(8):1571-1578. doi: 10.1097/IGC.0000000000001052.

PMID:
28604461
3.

Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.

Schrevel M, Osse EM, Prins FA, Trimbos JBMZ, Fleuren GJ, Gorter A, Jordanova ES.

Int J Oncol. 2017 Jun;50(6):1947-1954. doi: 10.3892/ijo.2017.3980. Epub 2017 May 3.

4.

Morphological and phenotypical features of ovarian metastases in breast cancer patients.

Peters IT, van der Steen MA, Huisman BW, Hilders CG, Smit VT, Vahrmeijer AL, Sier CF, Trimbos JB, Kuppen PJ.

BMC Cancer. 2017 Mar 21;17(1):206. doi: 10.1186/s12885-017-3191-y.

5.

Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study.

Peters IT, van Zwet EW, Smit VT, Liefers GJ, Kuppen PJ, Hilders CG, Trimbos JB.

PLoS One. 2017 Jan 26;12(1):e0168277. doi: 10.1371/journal.pone.0168277. eCollection 2017.

6.

The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer.

Van Meir H, du Burck IJ, de Kam ML, Welters MJP, van der Burg SH, Trimbos JBMZ, de Kroon CD, van Poelgeest MIE.

Eur J Gynaecol Oncol. 2017;38(1):25-32.

PMID:
29767860
7.

Surgical treatment of early-stage ovarian cancer.

Trimbos JB.

Best Pract Res Clin Obstet Gynaecol. 2017 May;41:60-70. doi: 10.1016/j.bpobgyn.2016.10.001. Epub 2016 Oct 8. Review.

PMID:
27894705
8.

Nerve-sparing radical hysterectomy versus conventional radical hysterectomy in early-stage cervical cancer. A systematic review and meta-analysis of survival and quality of life.

van Gent MD, Romijn LM, van Santen KE, Trimbos JB, de Kroon CD.

Maturitas. 2016 Dec;94:30-38. doi: 10.1016/j.maturitas.2016.08.005. Epub 2016 Aug 23. Review.

PMID:
27823742
9.

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.

van Poelgeest MI, Visconti VV, Aghai Z, van Ham VJ, Heusinkveld M, Zandvliet ML, Valentijn AR, Goedemans R, van der Minne CE, Verdegaal EM, Trimbos JB, van der Burg SH, Welters MJ.

Cancer Immunol Immunother. 2016 Dec;65(12):1451-1463. Epub 2016 Sep 12.

10.

A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.

Hoogstins CE, Tummers QR, Gaarenstroom KN, de Kroon CD, Trimbos JB, Bosse T, Smit VT, Vuyk J, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL.

Clin Cancer Res. 2016 Jun 15;22(12):2929-38. doi: 10.1158/1078-0432.CCR-15-2640.

11.

Noninvasive Detection of Metastases and Follicle Density in Ovarian Tissue Using Full-Field Optical Coherence Tomography.

Peters IT, Stegehuis PL, Peek R, Boer FL, van Zwet EW, Eggermont J, Westphal JR, Kuppen PJ, Trimbos JB, Hilders CG, Lelieveldt BP, van de Velde CJ, Bosse T, Dijkstra J, Vahrmeijer AL.

Clin Cancer Res. 2016 Nov 15;22(22):5506-5513. doi: 10.1158/1078-0432.CCR-16-0288. Epub 2016 May 16.

12.

Exploring Morphologic and Molecular Aspects of Endometrial Cancer Under Progesterone Treatment in the Context of Fertility Preservation.

van Gent MD, Nicolae-Cristea AR, de Kroon CD, Osse EM, Kagie MJ, Trimbos JB, Hazelbag HM, Smit VT, Bosse T.

Int J Gynecol Cancer. 2016 Mar;26(3):483-90. doi: 10.1097/IGC.0000000000000629.

PMID:
26825822
13.

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.

van Poelgeest MI, Welters MJ, Vermeij R, Stynenbosch LF, Loof NM, Berends-van der Meer DM, Löwik MJ, Hamming IL, van Esch EM, Hellebrekers BW, van Beurden M, Schreuder HW, Kagie MJ, Trimbos JB, Fathers LM, Daemen T, Hollema H, Valentijn AR, Oostendorp J, Oude Elberink JH, Fleuren GJ, Bosse T, Kenter GG, Stijnen T, Nijman HW, Melief CJ, van der Burg SH.

Clin Cancer Res. 2016 May 15;22(10):2342-50. doi: 10.1158/1078-0432.CCR-15-2594. Epub 2016 Jan 26.

14.

The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer.

Tummers QR, Hoogstins CE, Peters AA, de Kroon CD, Trimbos JB, van de Velde CJ, Frangioni JV, Vahrmeijer AL, Gaarenstroom KN.

PLoS One. 2015 Jun 25;10(6):e0129766. doi: 10.1371/journal.pone.0129766. eCollection 2015.

15.

Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer.

Punt S, Fleuren GJ, Kritikou E, Lubberts E, Trimbos JB, Jordanova ES, Gorter A.

Oncoimmunology. 2015 Feb 3;4(1):e984539. eCollection 2015 Jan.

16.
17.

Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival.

van Esch EM, van Poelgeest MI, Kouwenberg S, Osse EM, Trimbos JB, Fleuren GJ, Jordanova ES, van der Burg SH.

Int J Cancer. 2015 Feb 15;136(4):E95-106. doi: 10.1002/ijc.29174. Epub 2014 Sep 15.

18.

Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV-induced vulvar neoplasia.

van Esch EM, van Poelgeest MI, Trimbos JB, Fleuren GJ, Jordanova ES, van der Burg SH.

Int J Cancer. 2015 Feb 15;136(4):E85-94. doi: 10.1002/ijc.29173. Epub 2014 Sep 15.

19.

Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.

Spaans VM, Trietsch MD, Crobach S, Stelloo E, Kremer D, Osse EM, Haar NT, van Eijk R, Muller S, van Wezel T, Trimbos JB, Bosse T, Smit VT, Fleuren GJ.

PLoS One. 2014 Mar 26;9(3):e93451. doi: 10.1371/journal.pone.0093451. eCollection 2014.

20.

Nerve-sparing radical abdominal trachelectomy versus nerve-sparing radical hysterectomy in early-stage (FIGO IA2-IB) cervical cancer: a comparative study on feasibility and outcome.

van Gent MD, van den Haak LW, Gaarenstroom KN, Peters AA, van Poelgeest MI, Trimbos JB, de Kroon CD.

Int J Gynecol Cancer. 2014 May;24(4):735-43. doi: 10.1097/IGC.0000000000000114.

PMID:
24651626
21.

Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study.

Pieterse QD, Kenter GG, Maas CP, de Kroon CD, Creutzberg CL, Trimbos JB, Ter Kuile MM.

Int J Gynecol Cancer. 2013 Nov;23(9):1717-25. doi: 10.1097/IGC.0b013e3182a80a65.

PMID:
24172106
22.

Barrel index of bulky cervical tumours and intrauterine fluid determined by MRI as additional prognostic factors for survival.

van den Tillaart SA, Srámek A, Wasser MN, Trimbos JB.

Eur J Gynaecol Oncol. 2013;34(3):208-12.

PMID:
23967547
23.

Loss of heterozygosity and copy number alterations in flow-sorted bulky cervical cancer.

van den Tillaart SA, Corver WE, Ruano Neto D, ter Haar NT, Goeman JJ, Trimbos JB, Fleuren GJ, Oosting J.

PLoS One. 2013 Jul 9;8(7):e67414. doi: 10.1371/journal.pone.0067414. Print 2013.

24.

Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers.

Schaafsma BE, Verbeek FP, Peters AA, van der Vorst JR, de Kroon CD, van Poelgeest MI, Trimbos JB, van de Velde CJ, Frangioni JV, Vahrmeijer AL, Gaarenstroom KN.

BJOG. 2013 May;120(6):758-64. doi: 10.1111/1471-0528.12173. Epub 2013 Feb 19.

25.

Strength of sliding knots in multifilament resorbable suture materials.

van Leeuwen N, Trimbos JB.

Gynecol Surg. 2012 Nov;9(4):433-437. Epub 2012 Jun 16.

26.

Role of IL-12p40 in cervical carcinoma.

Zijlmans HJ, Punt S, Fleuren GJ, Trimbos JB, Kenter GG, Gorter A.

Br J Cancer. 2012 Dec 4;107(12):1956-62. doi: 10.1038/bjc.2012.488. Epub 2012 Oct 25.

27.

Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy.

van Esch EM, Welters MJ, Jordanova ES, Trimbos JB, van der Burg SH, van Poelgeest MI.

Expert Rev Vaccines. 2012 Jul;11(7):821-40. doi: 10.1586/erv.12.56. Review.

PMID:
22913259
28.

Single-visit approach of cervical cancer screening: see and treat in Indonesia.

Vet JN, Kooijman JL, Henderson FC, Aziz FM, Purwoto G, Susanto H, Surya IG, Budiningsih S, Cornain S, Fleuren GJ, Trimbos JB, Peters AA.

Br J Cancer. 2012 Aug 21;107(5):772-7. doi: 10.1038/bjc.2012.334. Epub 2012 Jul 31.

29.

Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer.

Schaafsma BE, van der Vorst JR, Gaarenstroom KN, Peters AA, Verbeek FP, de Kroon CD, Trimbos JB, van Poelgeest MI, Frangioni JV, van de Velde CJ, Vahrmeijer AL.

Gynecol Oncol. 2012 Oct;127(1):126-30. doi: 10.1016/j.ygyno.2012.07.002. Epub 2012 Jul 10.

30.

Genomic aberrations relate early and advanced stage ovarian cancer.

Zaal A, Peyrot WJ, Berns PM, van der Burg ME, Veerbeek JH, Trimbos JB, Cadron I, van Diest PJ, van Wieringen WN, Krijgsman O, Meijer GA, Piek JM, Timmers PJ, Vergote I, Verheijen RH, Ylstra B, Zweemer RP; EORTC GCG Translational Research Group.

Cell Oncol (Dordr). 2012 Jun;35(3):181-8. doi: 10.1007/s13402-012-0077-5. Epub 2012 May 12.

31.

CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.

Schrevel M, Karim R, ter Haar NT, van der Burg SH, Trimbos JB, Fleuren GJ, Gorter A, Jordanova ES.

Br J Cancer. 2012 Apr 24;106(9):1520-5. doi: 10.1038/bjc.2012.110.

32.

Analyses of multiple-site and concurrent Chlamydia trachomatis serovar infections, and serovar tissue tropism for urogenital versus rectal specimens in male and female patients.

Bax CJ, Quint KD, Peters RP, Ouburg S, Oostvogel PM, Mutsaers JA, Dörr PJ, Schmidt S, Jansen C, van Leeuwen AP, Quint WG, Trimbos JB, Meijer CJ, Morré SA.

Sex Transm Infect. 2011 Oct;87(6):503-7. doi: 10.1136/sti.2010.048173. Epub 2011 Aug 19.

PMID:
21856696
33.

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.

Gooden M, Lampen M, Jordanova ES, Leffers N, Trimbos JB, van der Burg SH, Nijman H, van Hall T.

Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10656-61. doi: 10.1073/pnas.1100354108. Epub 2011 Jun 13.

34.

Lymphadenectomy in ovarian cancer: standard of care or unnecessary risk.

Trimbos JB.

Curr Opin Oncol. 2011 Sep;23(5):507-11. doi: 10.1097/CCO.0b013e32834847e7. Review.

PMID:
21602676
35.

Power Doppler area in the diagnosis of endometrial cancer.

de Kroon CD, Hiemstra E, Trimbos JB, Jansen FW.

Int J Gynecol Cancer. 2010 Oct;20(7):1160-5.

PMID:
21495218
36.

Lymph node sampling and taking of blind biopsies are important elements of the surgical staging of early ovarian cancer.

Timmers PJ, Zwinderman K, Coens C, Vergote I, Trimbos JB.

Int J Gynecol Cancer. 2010 Oct;20(7):1142-7.

PMID:
21495216
37.

Patterns of parametrial involvement in radical hysterectomy specimens of cervical cancer patients.

van den Tillaart SA, Trimbos JB, Dreef EJ, Jordanova ES, Fleuren GJ.

Int J Gynecol Pathol. 2011 Mar;30(2):185-92. doi: 10.1097/PGP.0b013e3181fa5a7e.

PMID:
21293280
38.

Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer.

Schrevel M, Gorter A, Kolkman-Uljee SM, Trimbos JB, Fleuren GJ, Jordanova ES.

Mod Pathol. 2011 May;24(5):720-8. doi: 10.1038/modpathol.2010.239. Epub 2011 Jan 21.

39.

Nerve sparing in radical surgery for early-stage cervical cancer: yes we should!

de Kroon CD, Gaarenstroom KN, van Poelgeest MI, Peters AA, Trimbos JB.

Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S39-41. doi: 10.1111/IGC.0b013e3181f6381f. Review.

PMID:
20975361
40.

Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer.

Gorter A, Zijlmans HJ, van Gent H, Trimbos JB, Fleuren GJ, Jordanova ES.

Mod Pathol. 2010 Dec;23(12):1605-15. doi: 10.1038/modpathol.2010.154. Epub 2010 Aug 20.

41.

Abdominal scar recurrences of cervical cancer: incidence and characteristics: a case-control study.

van den Tillaart SA, Schoneveld A, Peters IT, Trimbos JB, Van Hylckama Vlieg A, Fleuren GJ, Peters AA.

Int J Gynecol Cancer. 2010 Aug;20(6):1031-40. doi: 10.1111/IGC.0b013e3181db5153.

PMID:
20683413
42.

The use of distilled water in the achievement of local hemostasis during surgery.

van den Tillaart SA, Busard MP, Trimbos JB.

Gynecol Surg. 2009 Sep;6(3):255-259. Epub 2009 Jan 17.

43.

Understanding the problem of inadequately staging early ovarian cancer.

Timmers PJ, Zwinderman AH, Coens C, Vergote I, Trimbos JB.

Eur J Cancer. 2010 Mar;46(5):880-4. doi: 10.1016/j.ejca.2009.12.012. Epub 2010 Jan 13.

PMID:
20074933
44.

TNM-like classification of radical hysterectomy.

Trimbos JB.

Gynecol Oncol. 2009 Jun;113(3):397-8. doi: 10.1016/j.ygyno.2009.02.024. Epub 2009 Apr 2. No abstract available.

PMID:
19344937
45.

Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial.

Timmers PJ, Zwinderman AH, Teodorovic I, Vergote I, Trimbos JB.

Int J Gynecol Cancer. 2009 Jan;19(1):88-93. doi: 10.1111/IGC.0b013e3181991546.

PMID:
19258948
46.

Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA.

van den Tillaart SA, Kenter GG, Peters AA, Dekker FW, Gaarenstroom KN, Fleuren GJ, Trimbos JB.

Int J Gynecol Cancer. 2009 Jan;19(1):39-45. doi: 10.1111/IGC.0b013e318197f675.

PMID:
19258939
47.

Hysteroscopic morcellator for removal of intrauterine polyps and myomas: a randomized controlled pilot study among residents in training.

van Dongen H, Emanuel MH, Wolterbeek R, Trimbos JB, Jansen FW.

J Minim Invasive Gynecol. 2008 Jul-Aug;15(4):466-71. doi: 10.1016/j.jmig.2008.02.002. Epub 2008 Apr 18.

PMID:
18588849
48.

Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study.

Hellebrekers BW, Trimbos-Kemper TC, Boesten L, Jansen FW, Kolkman W, Trimbos JB, Press RR, van Poelgeest MI, Emeis SJ, Kooistra T.

Fertil Steril. 2009 Apr;91(4):1204-14. doi: 10.1016/j.fertnstert.2008.01.052. Epub 2008 Mar 18.

PMID:
18353314
49.

Classification of radical hysterectomy adopted by the Gynecological Cancer Group of the European Organization for Research and Treatment of Cancer.

Mota F, Vergote I, Trimbos JB, Amant F, Siddiqui N, Del Rio A, Verheijen R, Zola P.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1136-8. Epub 2007 Nov 16.

PMID:
18021216
50.

An individual prediction of the future (disease-free) survival of patients with a history of early-stage cervical cancer, multistate model.

Pieterse QD, Kenter GG, Eilers PH, Trimbos JB.

Int J Gynecol Cancer. 2008 May-Jun;18(3):432-8. Epub 2007 Aug 10.

PMID:
17692087

Supplemental Content

Loading ...
Support Center